Arrowhead Research (ARWR) Ends 1Q with $77M to Focus on HBV and AAT; Piper Jaffray Reiterates Overweight
Go back to Arrowhead Research (ARWR) Ends 1Q with $77M to Focus on HBV and AAT; Piper Jaffray Reiterates Overweight| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 74.52 +0.11 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.41 | 52 Week High | $8.22 | |||
| Open | $74.53 | 52 Week Low | $3.07 | |||
| Day High | $75.45 | P/E | N/A | |||
| Day Low | $73.29 | EPS | $-1.30 | |||
| Volume | 1,182,200 | |||||
